ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting.

Matthew Capehorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.